NM_014817.4:c.2088G>C

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_014817.4(TRIL):​c.2088G>C​(p.Gln696His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000457 in 1,554,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 8/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000026 ( 0 hom. )

Consequence

TRIL
NM_014817.4 missense

Scores

2
2
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.60

Publications

0 publications found
Variant links:
Genes affected
TRIL (HGNC:22200): (TLR4 interactor with leucine rich repeats) TRIL is a component of the TLR4 (MIM 603030) complex and is induced in a number of cell types by lipopolysaccharide (LPS) (Carpenter et al., 2009 [PubMed 19710467]).[supplied by OMIM, Apr 2010]
CPVL-AS2 (HGNC:56138): (CPVL antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.054624468).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRILNM_014817.4 linkc.2088G>C p.Gln696His missense_variant Exon 1 of 1 ENST00000539664.3 NP_055632.2 Q7L0X0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRILENST00000539664.3 linkc.2088G>C p.Gln696His missense_variant Exon 1 of 1 6 NM_014817.4 ENSP00000479256.1 Q7L0X0

Frequencies

GnomAD3 genomes
AF:
0.000223
AC:
34
AN:
152254
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000515
AC:
8
AN:
155190
AF XY:
0.0000236
show subpopulations
Gnomad AFR exome
AF:
0.000764
Gnomad AMR exome
AF:
0.0000768
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000264
AC:
37
AN:
1401716
Hom.:
0
Cov.:
30
AF XY:
0.0000159
AC XY:
11
AN XY:
692618
show subpopulations
African (AFR)
AF:
0.000936
AC:
30
AN:
32054
American (AMR)
AF:
0.0000806
AC:
3
AN:
37202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25244
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36430
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79754
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42106
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5418
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1085138
Other (OTH)
AF:
0.0000685
AC:
4
AN:
58370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000223
AC:
34
AN:
152372
Hom.:
0
Cov.:
34
AF XY:
0.000282
AC XY:
21
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.000793
AC:
33
AN:
41598
American (AMR)
AF:
0.0000653
AC:
1
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000427
Hom.:
0
Bravo
AF:
0.000359
ExAC
AF:
0.0000352
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 02, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2088G>C (p.Q696H) alteration is located in exon 1 (coding exon 1) of the TRIL gene. This alteration results from a G to C substitution at nucleotide position 2088, causing the glutamine (Q) at amino acid position 696 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
23
DANN
Benign
0.86
DEOGEN2
Benign
0.033
T
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.055
T
MutationAssessor
Benign
0.97
L
PhyloP100
1.6
PrimateAI
Uncertain
0.74
T
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.50
MVP
0.16
GERP RS
2.2
Varity_R
0.12
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs572082033; hg19: chr7-28995575; API